Elawyers Elawyers
Ohio| Change

Turner v. Fallon, 97-1253 (1997)

Court: Court of Appeals for the First Circuit Number: 97-1253 Visitors: 13
Filed: Oct. 20, 1997
Latest Update: Mar. 02, 2020
Summary: Ronald Turner appealed.Charlotte Turner was diagnosed with breast cancer.for coverage would be reviewed further by Fallon.dosage chemotherapy without bone marrow transplantation.in this case.contractual remedies, including compensatory damages.relate to any employee benefit plan covered by ERISA.
USCA1 Opinion









UNITED STATES COURT OF APPEALS
FOR THE FIRST CIRCUIT
____________________

No. 97-1253

RONALD J. TURNER, AS ADMINISTRATOR OF THE
ESTATE OF CHARLOTTE M. TURNER, AND INDIVIDUALLY,

Plaintiff, Appellant,

v.

FALLON COMMUNITY HEALTH PLAN, INC.,

Defendant, Appellee.

____________________

APPEAL FROM THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF MASSACHUSETTS

[Hon. Nathaniel M. Gorton, U.S. District Judge] ___________________

____________________

Before

Boudin, Circuit Judge, _____________

Hill,* Senior Circuit Judge, ____________________

and Pollak,** Senior District Judge. _____________________

____________________

Burton Chandler with whom Seder & Chandler was on brief for ________________ _________________
appellant.
Daly D.E. Temchine with whom Thomas I. Elkind and Epstein Becker __________________ ________________ _______________
& Green, P.C. were on brief for appellee. _____________


____________________

October 20, 1997
____________________


____________________

*Of the Eleventh Circuit, sitting by designation.

**Of the Eastern District of Pennsylvania, sitting by designation.













BOUDIN, Circuit Judge. Ronald Turner, on behalf of _____________

himself and as administrator of the estate of his deceased

wife, Charlotte Turner, brought this suit in Massachusetts

state court against Fallon Community Health Plan, Inc.

("Fallon"). The gravamen was Fallon's refusal to provide

coverage for a treatment regime proposed by Charlotte Turner

and her doctor to address her metastasized breast cancer.

After the case was removed to federal district court, the

district court granted summary judgment for Fallon, and

Ronald Turner appealed.

The pertinent facts are largely undisputed. In 1991,

Charlotte Turner was diagnosed with breast cancer. The

disease was at first treated by surgery, chemotherapy and

radiation. In May 1993, tests showed that the cancer had

metastasized, was beyond control by conventional therapies,

and threatened Charlotte Turner with death within 12 to 18

months. Ronald Turner was employed by General Motors, and

Charlotte Turner was covered by the health coverage that

Fallon provided for family members of General Motors

employees.

Fallon is a health maintenance organization that

provides or reimburses health care for its members. Its

"Member Handbook," which is presented as "part of [the

member's] contract with [Fallon]," describes in detail the

various medical costs that Fallon will cover for



-2- -2-













beneficiaries. Among the express exclusions set forth in the __________

handbook was "bone marrow transplant for treatment of solid

tumors . . . ." Dr. Ronald Hochman, Charlotte Turner's

oncologist at Fallon, nevertheless concluded that Charlotte

Turner's only hope was an autologous bone marrow transplant,

a procedure by which the patient's own bone marrow is

extracted, stored and then reintroduced after the patient

receives high dosage chemotherapy. Marrow is the source of

vital white blood cells needed to fight infection and without

the transplant procedure, the high dosage chemotherapy would

impair the bone marrow's ability to continue to produce white

blood cells.

In May 1993, Fallon approved Charlotte Turner's request

that she be evaluated by Dana Farber Cancer Institute for

possible participation in its bone marrow transplant program.

Fallon continued to assert that a bone marrow transplant was

not a covered procedure for solid tumor cancer but said that

if the treatment was recommended by Dana Farber, the request

for coverage would be reviewed further by Fallon.

Ultimately, Dana Farber concluded that Charlotte Turner was

not eligible for the Dana Farber protocol because cancer

cells had already been detected in Charlotte Turner's bone

marrow.

Charlotte Turner then asked Fallon to cover her

examination for eligibility to enter a program being



-3- -3-













conducted by the Duke University Medical Center. In this

program, Duke not only removed bone marrow for

reimplantation, in aid of high dosage chemotherapy, but also

employed procedures to attempt to "purge" the marrow of its

cancer cells. Fallon declined to cover the cost of a "third

opinion." Charlotte Turner then had herself examined by

doctors at the Duke program who concluded that she might be

eligible to participate, subject to further testing. The

cost of her participation in the program was estimated at

$100,000.

In July 1993, Charlotte Turner and Dr. Hochman asked

Fallon to pay for her inclusion in the Duke program. In

August 1993, Fallon's Transplant Committee met to consider

Charlotte Turner's request and the broader question whether

coverage should be extended, on a case-by-case basis, to bone

marrow transplants to treat solid tumor cancers either under

the Dana Farber protocol or the Duke program or both. Dr.

Hochman supported Charlotte Turner's application for coverage

to the Duke program.

The Transplant Committee decided that, despite its

handbook exclusion, it would in the future extend coverage

for the Dana Farber protocol if it concluded in the

particular case that the treatment was critically necessary

and showed a strong likelihood of success. It concluded,

however, that the Duke program had as yet produced no



-4- -4-













adequate data suggesting a likelihood of success, and

therefore declined to extend coverage for the Duke program.

At Charlotte Turner's request, Fallon's Grievance Committee

held a hearing in September 1993 to review the decision of

the Transplant Committee, but in early October 1993, the

Grievance Committee upheld the denial of coverage for the

Duke program.

Immediately after the Grievance Committee's decision in

October 1993, Charlotte Turner underwent conventional low-

dosage chemotherapy without bone marrow transplantation. She

died on August 17, 1994. Ronald Turner then brought suit in

the Massachusetts superior court against Fallon charging it

with breach of contract, wrongful death and other state-law

claims. Fallon removed the case to federal district court on

the ground that state-law claims were preempted under ERISA--

the Employee Retirement Income Security Act of 1974, 29

U.S.C. 1001 et seq. See Metropolitan Life Ins. Co. v. ______ ___ ___________________________

Taylor, 481 U.S. 58, 66-67 (1987). ______

Ronald Turner responded by amending his complaint to

delete the state claims and to substitute a claim under

ERISA. The amended single-count complaint charged that

Fallon's denial of coverage for the Duke program "denied

Charlotte of the rights and benefits due under the policy and

was arbitrary, illegal, capricious, unreasonable and not made

in good faith and was a breach of [Fallon's] fiduciary duty



-5- -5-













which it owed to Charlotte." The complaint sought damages

and a trial by jury.

In March 1996, Fallon moved for summary judgment.

Ronald Turner opposed the motion and asked for further

discovery, which Fallon in turn opposed. The district court

then ruled that a civil ERISA action could be brought by a

plan beneficiary only (in the words of the statute) "to

recover benefits due to him under the terms of his plan, to

enforce his rights under the terms of the plan, or to clarify

his rights to future benefits under the terms of the plan."

29 U.S.C. 1132(a)(1)(B). Concluding that Ronald Turner's

damage action was not authorized by ERISA, the court ruled

that the case had to be dismissed and that further discovery

would be futile.

Ronald Turner then sought reconsideration and also

sought to amend the complaint to reassert the previously

withdrawn state-law claims. He argued that if ERISA provided

no federal remedy, it ought not be read to preempt his state-

law claims. Alternatively, he urged that if ERISA preempted

the state-law claims, then a federal remedy ought to be

inferred or created by the court to permit damages for

wrongful withholding of treatment under the employee benefits

plan. The district court wrote a thoughtful opinion denying

these requests.





-6- -6-













On this appeal, we begin with Ronald Turner's claim that

ERISA should be read to confer a claim for damages where, as

charged in the amended complaint, a beneficiary of the plan

has been denied "the rights and benefits due under the

policy" or has suffered "a breach of . . . fiduciary duty" in

the withholding of those benefits. ERISA is a comprehensive

federal statute that governs not only pension plans but also

nonpension benefit plans, including the General Motors health

benefits plan at issue in this case.

ERISA sets forth a half dozen civil enforcement

provisions. 29 U.S.C. 1132(a). Under the first such

provision, a beneficiary may bring a federal civil action "to

recover benefits due to him under the terms of his plan, to

enforce his rights under the terms of the plan, or to clarify

his rights to future benefits under the terms of the plan."

Id. 1132(a)(1)(B). The relief expressly provided is to ___

secure benefits under the plan rather than damages for a

breach of the plan. Here, treatment coverage is no longer of

any significance.

The other pertinent remedial provision authorizes civil

action by a beneficiary "to obtain other appropriate

equitable relief" to address violations of ERISA or to

enforce the plan. 29 U.S.C. 1132(a)(3)(B). The Supreme

Court recently held in Varity Corp. v. Howe, 116 S. Ct. 1065 ____________ ____

(1996), that this provision may permit equitable relief



-7- -7-













against a plan administrator for breaches of the fiduciary

duty imposed on such administrators by ERISA. See id. at ________

1075-79. But this provision is expressly limited to

providing equitable relief, and equitable relief is not being

sought in this case.

Ronald Turner points to no other specific remedial

provision in ERISA that might arguably be brought into play

in this case. In fact, the Supreme Court has stressed that

ERISA does not create compensatory or punitive damage

remedies where an administrator of a plan fails to provide

the benefits due under that plan. See Massachusetts Mut. ___ __________________

Life Ins. Co. v. Russell, 473 U.S. 134 (1985); see also ______________ _______ _________

Drinkwater v. Metropolitan Life Ins. Co., 846 F.2d 821, 825 __________ ___________________________

(1st Cir.), cert. denied, 488 U.S. 909 (1988). This is not a ____________

minor technicality: damage awards may increase effective

coverage but may also add significantly to the costs of

coverage.

The lack of an express damage remedy under ERISA does

not necessarily end the story. The federal courts have

regularly inferred or created remedies in the shadow of

federal statutes, although the practice has waned somewhat in

recent years. See, e.g., Northwest Airlines, Inc. v. __________ __________________________

Transport Workers, 451 U.S. 77, 94 (1981). But the Supreme _________________

Court has adamantly ruled that ERISA's express remedies are a

signal to courts not to create additional remedies of their



-8- -8-













own. Russell, 473 U.S. at 145-48. See also Reich v. Rowe, _______ ________ _____ ____

20 F.3d 25, 31-33 (1st Cir. 1994); Drinkwater, 846 F.2d at __________

824.

In the alternative, Ronald Turner argues that ERISA, if

it provides no damage remedy of its own either expressly or

by implication, should at least not be taken to preclude

existing state remedies. Absent preemption, a health

benefits plan like Fallon's could certainly be treated as a

contract enforceable under state law and subject to the usual

contractual remedies, including compensatory damages.

Depending on the jurisdiction, state law might provide even

more substantial relief, including punitive damages.

ERISA contains a vague but broadly worded preemption

provision. With exceptions not relevant here, it provides

that the pertinent subchapter of ERISA shall supersede any

and all "State laws insofar as they may now or hereafter

relate to any employee benefit plan" covered by ERISA. 29

U.S.C. 1144(a). However this general language might

otherwise have been read, the Supreme Court has construed it

to preclude state claims to enforce rights under an ERISA

plan or obtain damages for the wrongful withholding of those

rights, Pilot Life Ins. Co. v. Dedeaux, 481 U.S. 41, 52-57 ____________________ _______

(1987), and this construction has been repeatedly followed.1

____________________

1See, e.g., Ingersoll-Rand Co. v. McClendon, 498 U.S. _________ __________________ _________
133, 144 (1990); Carlo v. Reed Rolled Thread Die Co., 49 F.3d _____ __________________________
790, 794 (1st Cir. 1995); Rosario-Cordero v. Crowley Towing & _______________ ________________

-9- -9-













The Supreme Court has recently set some new limits on

preemption by holding that certain state laws were not

sufficiently "related" to ERISA to deserve preemption. See ___

De Buono v. NYSA-ILA Medical & Clinical Servs. Fund, 117 S. ________ ________________________________________

Ct. 1747, 1752-53 (1997); California Div. of Labor Standards __________________________________

Enforcement v. Dillingham Constr., N.A., 117 S. Ct. 832, 842 ___________ _________________________

(1997). But neither of these cases involved a state's

attempt to provide state remedies for what is in essence a

plan administrator's refusal to pay allegedly promised

benefits. It would be difficult to think of a state law that

"relates" more closely to an employee benefit plan than one

that affords remedies for the breach of obligations under

that plan.

Ronald Turner more or less admits that existing Supreme

Court precedent is against him, both as to an implicit

federal cause of action and the preemption of state claims.

But he says that it is grossly unjust to deny any remedy,

either state or federal, to compensate in damages the victim,

family or estate of one who has been wrongfully denied

promised health-care benefits. Further, he argues that this

gap provides a cruel incentive for plan administrators to

withhold treatment or delay it as long as possible, since the


____________________

Transp. Co., 46 F.3d 120, 126 (1st Cir. 1995); Nash v. ____________ ____
Trustees of Boston Univ., 946 F.2d 960, 964 n.8 (1st Cir. _________________________
1991); Wickman v. Northwestern Nat'l Ins. Co., 908 F.2d 1077, _______ ___________________________
1082 (1st Cir.), cert. denied, 498 U.S. 1013 (1990). ____________

-10- -10-













claim for benefits may be mooted by the beneficiary's death.



There are in reality two quite different problems of law

and policy entangled in this argument. The one that Ronald

Turner seeks to present is the case of a beneficiary

wrongfully denied promised benefits. There is reason to

doubt that that is the true problem in this case (a point to ____

which we will return), but such cases are easy to imagine and

certain to occur. Compensatory damages are a conventional

and potent remedy that might indeed deter misconduct and

mitigate loss, although the cost of the plan would also be

increased.

On the other hand, some might think it perverse to dwell

on damage remedies, which apply where the patient has died or

already suffered injury, and might urge instead that courts

improve access to equitable relief. This remedy, already _________

available under ERISA, can address a wrongful denial of

benefits while the patient is still alive and unharmed.

Although Ronald Turner says that such judicial relief is

readily frustrated by exhaustion of remedies rules, a failure

to exhaust is easily forgiven for good reason, and no reason

is better than an imminent threat to life or health. E.g., ____

Portela-Gonzalez v. Secretary of the Navy, 109 F.3d 74, 77 ________________ ______________________

(1st Cir. 1997); see also DePina v. General Dynamics Corp., ________ ______ ______________________

674 F. Supp. 46, 49 (D. Mass. 1987).



-11- -11-













In all events, it is certainly a matter for reasonable

debate whether a damage remedy should be added, either by

judicial interpolation or by Congress. But only the Supreme

Court could alter the existing case law that precludes such a

remedy. And whether or not Congress ever thought about the

impact on health care in particular when it wrote ERISA's

remedies and preemption provisions, Congress is well equipped

to revisit the issue and alter the statutory language that

now stands as a bar.

Although the question of a damages remedy is an

important one, it likely has n
Source:  CourtListener

Can't find what you're looking for?

Post a free question on our public forum.
Ask a Question
Search for lawyers by practice areas.
Find a Lawyer